APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunology-Oncology Elisa Kits

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Immunology-Oncology Elisa Kits Market Outlook and Growth Opportunities 2026

27 December 2025191 pages

Choose your research edition.

Industry ResearchImmunology-Oncology Elisa Kits Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunology-Oncology Elisa Kits Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Immunology-Oncology Elisa Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunology-Oncology Elisa Kits Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunology-Oncology Elisa Kits Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Immunology-Oncology Elisa Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immunology-Oncology Elisa Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immunology-Oncology Elisa Kits market include Thermo Fisher Scientific, MilliporeSigma (Merck KGaA), RayBiotech Life, Inc., Enzo Life Sciences, ELISAGEN Biotech, Creative Diagnostics, Bio-Techne Corporation (R&D Systems), BioLegend (part of PerkinElmer) and BD Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immunology-Oncology Elisa Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunology-Oncology Elisa Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunology-Oncology Elisa Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunology-Oncology Elisa Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunology-Oncology Elisa Kits Segment by Company

Thermo Fisher Scientific

MilliporeSigma (Merck KGaA)

RayBiotech Life, Inc.

Enzo Life Sciences

ELISAGEN Biotech

Creative Diagnostics

Bio-Techne Corporation (R&D Systems)

BioLegend (part of PerkinElmer)

BD Biosciences

Abcam

Immunology-Oncology Elisa Kits Segment by Type

Direct ELISA Kit

Indirect ELISA Kit

Immunology-Oncology Elisa Kits Segment by Application

Cancer Diagnosis

Pharmaceutical Industry

Other

Immunology-Oncology Elisa Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Immunology-Oncology Elisa Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Immunology-Oncology Elisa Kits market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immunology-Oncology Elisa Kits significant trends, drivers, influence factors in global and regions.

6. To analyze Immunology-Oncology Elisa Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology-Oncology Elisa Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunology-Oncology Elisa Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology-Oncology Elisa Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunology-Oncology Elisa Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunology-Oncology Elisa Kits industry.

Chapter 3: Detailed analysis of Immunology-Oncology Elisa Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Immunology-Oncology Elisa Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Immunology-Oncology Elisa Kits in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immunology-Oncology Elisa Kits Industry Trends Table 2. Immunology-Oncology Elisa Kits Industry Drivers Table 3. Immunology-Oncology Elisa Kits Industry Opportunities and Challenges Table 4. Immunology-Oncology Elisa Kits Industry Restraints Table 5. Global Immunology-Oncology Elisa Kits Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immunology-Oncology Elisa Kits Revenue Share by Company (2021-2026) Table 7. Global Immunology-Oncology Elisa Kits Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Immunology-Oncology Elisa Kits Sales Volume Share by Company (2021-2026) Table 9. Global Immunology-Oncology Elisa Kits Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Immunology-Oncology Elisa Kits Company Ranking, (2024-2026) & (USD Million) Table 11. Global Immunology-Oncology Elisa Kits Key Company Manufacturing Base & Headquarters Table 12. Global Immunology-Oncology Elisa Kits Company, Product Type & Application Table 13. Global Immunology-Oncology Elisa Kits Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunology-Oncology Elisa Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Direct ELISA Kit Table 18. Significant Companies of Indirect ELISA Kit Table 19. Global Immunology-Oncology Elisa Kits Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Immunology-Oncology Elisa Kits Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Immunology-Oncology Elisa Kits Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Immunology-Oncology Elisa Kits Sales Volume Share by Type (2021-2026) Table 23. Global Immunology-Oncology Elisa Kits Sales Volume Share by Type (2027-2032) Table 24. Global Immunology-Oncology Elisa Kits Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Immunology-Oncology Elisa Kits Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Immunology-Oncology Elisa Kits Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Immunology-Oncology Elisa Kits Sales Value Share by Type (2021-2026) Table 28. Global Immunology-Oncology Elisa Kits Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cancer Diagnosis Table 30. Significant Companies of Pharmaceutical Industry Table 31. Significant Companies of Other Table 32. Global Immunology-Oncology Elisa Kits Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Immunology-Oncology Elisa Kits Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Immunology-Oncology Elisa Kits Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Immunology-Oncology Elisa Kits Sales Volume Share by Application (2021-2026) Table 36. Global Immunology-Oncology Elisa Kits Sales Volume Share by Application (2027-2032) Table 37. Global Immunology-Oncology Elisa Kits Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Immunology-Oncology Elisa Kits Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Immunology-Oncology Elisa Kits Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Immunology-Oncology Elisa Kits Sales Value Share by Application (2021-2026) Table 41. Global Immunology-Oncology Elisa Kits Sales Value Share by Application (2027-2032) Table 42. Global Immunology-Oncology Elisa Kits Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Immunology-Oncology Elisa Kits Sales by Region (2021-2026) & (K Units) Table 44. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2021-2026) Table 45. Global Immunology-Oncology Elisa Kits Sales by Region (2027-2032) & (K Units) Table 46. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2027-2032) Table 47. Global Immunology-Oncology Elisa Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Immunology-Oncology Elisa Kits Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Immunology-Oncology Elisa Kits Sales Value Share by Region (2021-2026) Table 50. Global Immunology-Oncology Elisa Kits Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Immunology-Oncology Elisa Kits Sales Value Share by Region (2027-2032) Table 52. Global Immunology-Oncology Elisa Kits Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Immunology-Oncology Elisa Kits Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Immunology-Oncology Elisa Kits Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Immunology-Oncology Elisa Kits Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 57. Global Immunology-Oncology Elisa Kits Sales Market Share by Country (2021-2026) Table 58. Global Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 59. Global Immunology-Oncology Elisa Kits Sales Market Share by Country (2027-2032) Table 60. Global Immunology-Oncology Elisa Kits Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Immunology-Oncology Elisa Kits Sales Value Market Share by Country (2021-2026) Table 62. Global Immunology-Oncology Elisa Kits Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Immunology-Oncology Elisa Kits Sales Value Market Share by Country (2027-2032) Table 64. Thermo Fisher Scientific Company Information Table 65. Thermo Fisher Scientific Business Overview Table 66. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio Table 68. Thermo Fisher Scientific Recent Development Table 69. MilliporeSigma (Merck KGaA) Company Information Table 70. MilliporeSigma (Merck KGaA) Business Overview Table 71. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio Table 73. MilliporeSigma (Merck KGaA) Recent Development Table 74. RayBiotech Life, Inc. Company Information Table 75. RayBiotech Life, Inc. Business Overview Table 76. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio Table 78. RayBiotech Life, Inc. Recent Development Table 79. Enzo Life Sciences Company Information Table 80. Enzo Life Sciences Business Overview Table 81. Enzo Life Sciences Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio Table 83. Enzo Life Sciences Recent Development Table 84. ELISAGEN Biotech Company Information Table 85. ELISAGEN Biotech Business Overview Table 86. ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio Table 88. ELISAGEN Biotech Recent Development Table 89. Creative Diagnostics Company Information Table 90. Creative Diagnostics Business Overview Table 91. Creative Diagnostics Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio Table 93. Creative Diagnostics Recent Development Table 94. Bio-Techne Corporation (R&D Systems) Company Information Table 95. Bio-Techne Corporation (R&D Systems) Business Overview Table 96. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio Table 98. Bio-Techne Corporation (R&D Systems) Recent Development Table 99. BioLegend (part of PerkinElmer) Company Information Table 100. BioLegend (part of PerkinElmer) Business Overview Table 101. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio Table 103. BioLegend (part of PerkinElmer) Recent Development Table 104. BD Biosciences Company Information Table 105. BD Biosciences Business Overview Table 106. BD Biosciences Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio Table 108. BD Biosciences Recent Development Table 109. Abcam Company Information Table 110. Abcam Business Overview Table 111. Abcam Immunology-Oncology Elisa Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Abcam Immunology-Oncology Elisa Kits Product Portfolio Table 113. Abcam Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Immunology-Oncology Elisa Kits Distributors List Table 117. Immunology-Oncology Elisa Kits Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Immunology-Oncology Elisa Kits Product Image Figure 2. Global Immunology-Oncology Elisa Kits Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunology-Oncology Elisa Kits Sales Value (2021-2032) & (US$ Million) Figure 4. Global Immunology-Oncology Elisa Kits Sales (2021-2032) & (K Units) Figure 5. Global Immunology-Oncology Elisa Kits Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Immunology-Oncology Elisa Kits Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Direct ELISA Kit Image Figure 10. Indirect ELISA Kit Image Figure 11. Global Immunology-Oncology Elisa Kits Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Immunology-Oncology Elisa Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Immunology-Oncology Elisa Kits Sales Volume Share by Type (2021-2032) Figure 14. Global Immunology-Oncology Elisa Kits Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Immunology-Oncology Elisa Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Immunology-Oncology Elisa Kits Sales Value Share by Type (2021-2032) Figure 17. Cancer Diagnosis Image Figure 18. Pharmaceutical Industry Image Figure 19. Other Image Figure 20. Global Immunology-Oncology Elisa Kits Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Immunology-Oncology Elisa Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Immunology-Oncology Elisa Kits Sales Volume Share by Application (2021-2032) Figure 23. Global Immunology-Oncology Elisa Kits Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Immunology-Oncology Elisa Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Immunology-Oncology Elisa Kits Sales Value Share by Application (2021-2032) Figure 26. Global Immunology-Oncology Elisa Kits Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Immunology-Oncology Elisa Kits Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Immunology-Oncology Elisa Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Immunology-Oncology Elisa Kits Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Immunology-Oncology Elisa Kits Sales Value (2021-2032) & (US$ Million) Figure 31. North America Immunology-Oncology Elisa Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Immunology-Oncology Elisa Kits Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Immunology-Oncology Elisa Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Immunology-Oncology Elisa Kits Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Immunology-Oncology Elisa Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Immunology-Oncology Elisa Kits Sales Value (2021-2032) & (US$ Million) Figure 37. South America Immunology-Oncology Elisa Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Immunology-Oncology Elisa Kits Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Immunology-Oncology Elisa Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Immunology-Oncology Elisa Kits Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Immunology-Oncology Elisa Kits Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Direct ELISA Kit
  • Indirect ELISA Kit
Applications
  • Cancer Diagnosis
  • Pharmaceutical Industry
  • Other
Companies covered
  • Thermo Fisher Scientific
  • MilliporeSigma (Merck KGaA)
  • RayBiotech Life, Inc.
  • Enzo Life Sciences
  • ELISAGEN Biotech
  • Creative Diagnostics
  • Bio-Techne Corporation (R&D Systems)
  • BioLegend (part of PerkinElmer)
  • BD Biosciences
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunology-Oncology Elisa Kits Sales Value (2021-2032)
  4. 1.2.2 Global Immunology-Oncology Elisa Kits Sales Volume (2021-2032)
  5. 1.2.3 Global Immunology-Oncology Elisa Kits Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Immunology-Oncology Elisa Kits Market Dynamics
  1. 2.1 Immunology-Oncology Elisa Kits Industry Trends
  2. 2.2 Immunology-Oncology Elisa Kits Industry Drivers
  3. 2.3 Immunology-Oncology Elisa Kits Industry Opportunities and Challenges
  4. 2.4 Immunology-Oncology Elisa Kits Industry Restraints
3 Immunology-Oncology Elisa Kits Market by Company
  1. 3.1 Global Immunology-Oncology Elisa Kits Company Revenue Ranking in 2025
  2. 3.2 Global Immunology-Oncology Elisa Kits Revenue by Company (2021-2026)
  3. 3.3 Global Immunology-Oncology Elisa Kits Sales Volume by Company (2021-2026)
  4. 3.4 Global Immunology-Oncology Elisa Kits Average Price by Company (2021-2026)
  5. 3.5 Global Immunology-Oncology Elisa Kits Company Ranking (2024-2026)
  6. 3.6 Global Immunology-Oncology Elisa Kits Company Manufacturing Base and Headquarters
  7. 3.7 Global Immunology-Oncology Elisa Kits Company Product Type and Application
  8. 3.8 Global Immunology-Oncology Elisa Kits Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Immunology-Oncology Elisa Kits Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Immunology-Oncology Elisa Kits Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Immunology-Oncology Elisa Kits Market by Type
  1. 4.1 Immunology-Oncology Elisa Kits Type Introduction
  2. 4.1.1 Direct ELISA Kit
  3. 4.1.2 Indirect ELISA Kit
  4. 4.2 Global Immunology-Oncology Elisa Kits Sales Volume by Type
  5. 4.2.1 Global Immunology-Oncology Elisa Kits Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Immunology-Oncology Elisa Kits Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Immunology-Oncology Elisa Kits Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Immunology-Oncology Elisa Kits Sales Value by Type
  9. 4.3.1 Global Immunology-Oncology Elisa Kits Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Immunology-Oncology Elisa Kits Sales Value by Type (2021-2032)
  11. 4.3.3 Global Immunology-Oncology Elisa Kits Sales Value Share by Type (2021-2032)
5 Immunology-Oncology Elisa Kits Market by Application
  1. 5.1 Immunology-Oncology Elisa Kits Application Introduction
  2. 5.1.1 Cancer Diagnosis
  3. 5.1.2 Pharmaceutical Industry
  4. 5.1.3 Other
  5. 5.2 Global Immunology-Oncology Elisa Kits Sales Volume by Application
  6. 5.2.1 Global Immunology-Oncology Elisa Kits Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immunology-Oncology Elisa Kits Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Immunology-Oncology Elisa Kits Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Immunology-Oncology Elisa Kits Sales Value by Application
  10. 5.3.1 Global Immunology-Oncology Elisa Kits Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Immunology-Oncology Elisa Kits Sales Value by Application (2021-2032)
  12. 5.3.3 Global Immunology-Oncology Elisa Kits Sales Value Share by Application (2021-2032)
6 Immunology-Oncology Elisa Kits Regional Sales and Value Analysis
  1. 6.1 Global Immunology-Oncology Elisa Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunology-Oncology Elisa Kits Sales by Region (2021-2032)
  3. 6.2.1 Global Immunology-Oncology Elisa Kits Sales by Region: 2021-2026
  4. 6.2.2 Global Immunology-Oncology Elisa Kits Sales by Region (2027-2032)
  5. 6.3 Global Immunology-Oncology Elisa Kits Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Immunology-Oncology Elisa Kits Sales Value by Region (2021-2032)
  7. 6.4.1 Global Immunology-Oncology Elisa Kits Sales Value by Region: 2021-2026
  8. 6.4.2 Global Immunology-Oncology Elisa Kits Sales Value by Region (2027-2032)
  9. 6.5 Global Immunology-Oncology Elisa Kits Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Immunology-Oncology Elisa Kits Sales Value (2021-2032)
  12. 6.6.2 North America Immunology-Oncology Elisa Kits Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Immunology-Oncology Elisa Kits Sales Value (2021-2032)
  15. 6.7.2 Europe Immunology-Oncology Elisa Kits Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Immunology-Oncology Elisa Kits Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Immunology-Oncology Elisa Kits Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Immunology-Oncology Elisa Kits Sales Value (2021-2032)
  21. 6.9.2 South America Immunology-Oncology Elisa Kits Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Immunology-Oncology Elisa Kits Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Immunology-Oncology Elisa Kits Sales Value Share by Country, 2025 VS 2032
7 Immunology-Oncology Elisa Kits Country-level Sales and Value Analysis
  1. 7.1 Global Immunology-Oncology Elisa Kits Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immunology-Oncology Elisa Kits Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
  4. 7.3.1 Global Immunology-Oncology Elisa Kits Sales by Country (2021-2026)
  5. 7.3.2 Global Immunology-Oncology Elisa Kits Sales by Country (2027-2032)
  6. 7.4 Global Immunology-Oncology Elisa Kits Sales Value by Country (2021-2032)
  7. 7.4.1 Global Immunology-Oncology Elisa Kits Sales Value by Country (2021-2026)
  8. 7.4.2 Global Immunology-Oncology Elisa Kits Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Immunology-Oncology Elisa Kits Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Immunology-Oncology Elisa Kits Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Immunology-Oncology Elisa Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 MilliporeSigma (Merck KGaA)
  8. 8.2.1 MilliporeSigma (Merck KGaA) Company Information
  9. 8.2.2 MilliporeSigma (Merck KGaA) Business Overview
  10. 8.2.3 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio
  12. 8.2.5 MilliporeSigma (Merck KGaA) Recent Developments
  13. 8.3 RayBiotech Life, Inc.
  14. 8.3.1 RayBiotech Life, Inc. Company Information
  15. 8.3.2 RayBiotech Life, Inc. Business Overview
  16. 8.3.3 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio
  18. 8.3.5 RayBiotech Life, Inc. Recent Developments
  19. 8.4 Enzo Life Sciences
  20. 8.4.1 Enzo Life Sciences Company Information
  21. 8.4.2 Enzo Life Sciences Business Overview
  22. 8.4.3 Enzo Life Sciences Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio
  24. 8.4.5 Enzo Life Sciences Recent Developments
  25. 8.5 ELISAGEN Biotech
  26. 8.5.1 ELISAGEN Biotech Company Information
  27. 8.5.2 ELISAGEN Biotech Business Overview
  28. 8.5.3 ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio
  30. 8.5.5 ELISAGEN Biotech Recent Developments
  31. 8.6 Creative Diagnostics
  32. 8.6.1 Creative Diagnostics Company Information
  33. 8.6.2 Creative Diagnostics Business Overview
  34. 8.6.3 Creative Diagnostics Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio
  36. 8.6.5 Creative Diagnostics Recent Developments
  37. 8.7 Bio-Techne Corporation (R&D Systems)
  38. 8.7.1 Bio-Techne Corporation (R&D Systems) Company Information
  39. 8.7.2 Bio-Techne Corporation (R&D Systems) Business Overview
  40. 8.7.3 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio
  42. 8.7.5 Bio-Techne Corporation (R&D Systems) Recent Developments
  43. 8.8 BioLegend (part of PerkinElmer)
  44. 8.8.1 BioLegend (part of PerkinElmer) Company Information
  45. 8.8.2 BioLegend (part of PerkinElmer) Business Overview
  46. 8.8.3 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio
  48. 8.8.5 BioLegend (part of PerkinElmer) Recent Developments
  49. 8.9 BD Biosciences
  50. 8.9.1 BD Biosciences Company Information
  51. 8.9.2 BD Biosciences Business Overview
  52. 8.9.3 BD Biosciences Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio
  54. 8.9.5 BD Biosciences Recent Developments
  55. 8.10 Abcam
  56. 8.10.1 Abcam Company Information
  57. 8.10.2 Abcam Business Overview
  58. 8.10.3 Abcam Immunology-Oncology Elisa Kits Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Abcam Immunology-Oncology Elisa Kits Product Portfolio
  60. 8.10.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunology-Oncology Elisa Kits Value Chain Analysis
  2. 9.1.1 Immunology-Oncology Elisa Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunology-Oncology Elisa Kits Sales Mode & Process
  6. 9.2 Immunology-Oncology Elisa Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunology-Oncology Elisa Kits Distributors
  9. 9.2.3 Immunology-Oncology Elisa Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst